1 year of experience with maribavir: redefining treatment standards post-transplantation - Interview with Prof. Dr. A. De Becker

Prof. Ann De Becker, hematologist at UZ Brussel, is sharing her experience with Livtencity 1 year after launch. 

Join us for the latest advancements, therapeutic strategies and insights in CMV management post-transplantation.